executives with prohibited characteristics, (4) putting in place issuer due diligence and product screening systems, (5) examining issuers? business plans and the source codes of smart contract, (6) conducting

ดังนี้ (1) บกพร่องในการตรวจสอบหรือสอบทาน (due diligence) ในรายการขายเงินลงทุนที่มีนัยสำคัญต่องบการเงินของผู้ขออนุญาต และในการจ่ายค่าที่ปรึกษาออกไปจำนวนสูง ทั้งที่อาจไม่ได้รับบริการจริง ส่งผลต่อความรัดกุม

million in Q1’2019 primarily due to the commercial operations of ABPR3, ABPR4 and ABPR5 SPP projects in February, June and October 2018 respectively and the SPP1 acquisition in March 2019. • Sales and

2018, the Company has cost of services at Baht 443.49 million which increased compared to the year 2017 by Baht 53.11 million or equivalent to 13.60% mainly due to increasing medical and other supplies

sale revenue increase by 4.43% results in better profit margin compare to the year 2018 which is increase by 10.87 million baht due to the company has more capability to control waste thus, the

 Profits increased 40% to THB 539m in Q2 2017 from THB 384m in Q2 2016. Net Profit increased 62% to THB 676m in Q217 from THB 417m in Q216, due to higher operating profits and exchange gain in Q217. Quarter

2016 and 2017 were Baht 127 million and Baht 151.1 million, respectively, which grew at a rate of 18.98% due to increasing number of non-capitation patients, the growth of average revenue per visit for

baht or 0.2 percent increase from the same quarter of the previous year and 8.7 percent increase from the 1st quarter of 2017. This growth is due to the release of new products, for example, the “Family

. Due to this business has low gross profit margin, to build up more sales revenue will result in good net profit. Sales revenue The Company had total sales revenue of Baht 863.2 million in Q3/2017

255.2 2.8% The mainly factor of the increase in sales revenue of the product category DAIWA which was an increase in sales due to price reduction promotion campaign for the dealer group. Other income 9.7